Clinically, using estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) as markers, breast cancer patients are mainly classified into ER+, HER2 + and triple-negative breast cancer (TNBC) subtypes. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.